Post-apocalyptic discourse and the new modesty: governing preimplantation genetic diagnosis in the UK

2011 ◽  
pp. 189-214
Author(s):  
Kathrin Braun ◽  
Susanne Schultz
2008 ◽  
Vol 18 (2) ◽  
pp. 131-136 ◽  
Author(s):  
Georgia Kakourou ◽  
Seema Dhanjal ◽  
Thalia Mamas ◽  
Sarah Gotts ◽  
Alpesh Doshi ◽  
...  

2007 ◽  
Vol 65 (6) ◽  
pp. 1094-1105 ◽  
Author(s):  
Clare Williams ◽  
Kathryn Ehrich ◽  
Bobbie Farsides ◽  
Rosamund Scott

Medical Law ◽  
2019 ◽  
pp. 792-860
Author(s):  
Emily Jackson

All books in this flagship series contain carefully selected substantial extracts from key cases, legislation, and academic debate, providing students with a stand-alone resource. This chapter discusses the regulation of assisted conception. It first examines the regulation of assisted conception in the UK, which involves a detailed look at the legislation: the Human Fertilisation and Embryology Act 1990, and the work of the Human Fertilisation and Embryology Authority (HFEA). The chapter analyses: the licensing procedures through which clinics are inspected and authorized to perform certain procedures; access to treatment; consent to the use of gametes (sperm and eggs); gamete donation; rules governing the parentage of children; and preimplantation genetic diagnosis (PGD). It also considers mitochondrial transfer and genome editing.


2008 ◽  
Vol 3 (4) ◽  
pp. 176-179 ◽  
Author(s):  
Eva C A Asscher

Developments in biotechnology present difficult social and ethical challenges that need to be resolved by regulators among others. One crucial problem for regulators of new technologies is to ensure that regulation is both clear and sufficiently flexible to respond to new developments. This is particularly difficult to achieve in contentious fields such as medical biotechnology. In the European Union there is a divergence in the solutions to this problem which has lead to different regulatory frameworks for medical biotechnology. This paper compares and contrasts the British and Dutch regulatory frameworks for the selection of embryos by preimplantation genetic diagnosis as an example of the regulation of medical biotechnology. Some of the outcomes of the regulatory choices and possible reasons behind the divergent frameworks are discussed, such as the ethical outlooks and political systems in these countries.


2014 ◽  
Vol 74 (S 01) ◽  
Author(s):  
KJ Heiliger ◽  
D Gutknecht ◽  
C Adelfalk ◽  
A Eder ◽  
M Bals-Pratsch ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document